Group-based [ADAPT] Versus One-to-one [Usual] Occupational Therapy (Go:OT Trial) (Go:OT)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06058754 |
Recruitment Status :
Recruiting
First Posted : September 28, 2023
Last Update Posted : September 28, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Chronic Condition Chronic Disease Chronic Conditions, Multiple | Behavioral: The ADAPT Program Behavioral: UOT | Not Applicable |
Background: The number of people living with chronic conditions limiting the ability to perform activities of daily living (ADL) tasks is increasing. Occupational therapists are trained to deliver interventions to improve ADL ability, e.g. by adapting and adjusting daily routines and physical environments. Municipality occupational therapy (OT) interventions are usually delivered as one-to-one sessions in the client´s home. While this intervention format might be effective in improving ADL ability, a group-based intervention format might be as effective but more cost-effective and hold other secondary gains. Guided by the British Medical Research Council's guidance (MRC) on how to develop and evaluate complex interventions, the ADAPT Program, a peer-exchange group-based program, was developed, piloted, and evaluated for its functioning and feasibility in municipality settings. These studies provided initial evidence for the ADAPT Programs effectiveness in improving ADL ability and suggests gains as improved well-being. Hence, the current phase concerns a full-scale evaluation of the ADAPT Program including evaluation of effectiveness, processes and cost-effectiveness.
Material and Methods: The randomized controlled trial (RCT), initiated with an external pilot (n=12), will include 130 home dwelling persons with decreased ADL ability following chronic conditions. Participants are randomized to either ADAPT Program (experimental) or usual OT (control).
Primary outcome: Observed ADL motor ability measured with the Assessment of Motor and Process Skills (AMPS).
Secondary outcomes: Observed ADL process ability measured with the AMPS; patient reported ADL task Performance and Satisfaction measured with the ADL-Interview (ADL-I, Performance and Satisfaction scores); Well-being assessed with the World Health Organisation-Five Well Being Index (WHO-5); Health-related Quality of Life assessed with the European Quality of Life - 5 Dimensions (EQ-5D).
Exploratory outcomes include patient reported changes, using transition scales to evaluate participants´ experience of a) changed ADL task performance and satisfaction, b) changed problem-solving skills, c) changed quality of life, d) changed global health, e) changed needs for assistance. Finally, participants are to rate their overall experience of the allocated occupational therapy intervention.
Data collection: Effectiveness and cost-effectiveness data are collected at baseline and post intervention i.e., 3-months (week 12) and 6-months (week 26) from baseline. Costs will be estimated based on micro costing and national registries. Effects will be Quality Adjusted Life Years and changes in AMPS ADL motor ability. Process evaluation data will be collected using registration forms and semi-structured qualitative interviews.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 130 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | A single-center, double-blinded, randomized, parallel-group, equivalence 6-months follow-up study with external pilot, effect, process and economic evaluations |
Masking: | Double (Participant, Outcomes Assessor) |
Masking Description: | Participants are informed that they will be allocated to one of two occupational therapy intervention programs that both aims to improve ADL ability, but overall primarily differ in terms of their format i.e. a group-based versus a one-to-one intervention program format. Participants are not informed, which of the two types of formats that are the new experimental intervention format (ADAPT) nor control (UOT). Baseline assessments are conducted prior to randomization by a local employed occupational therapists, who is instructed not to reveal which intervention that is the new experimental intervention. The post and follow-up assessors, a research occupational therapy assistant employed at the Parker Institute, is also instructed not to disclose which intervention that is the new experimental one. Finally, all participants are reminded not to disclose any details, that may provide the outcome assessors with insights regarding their allocated study arm. |
Primary Purpose: | Health Services Research |
Official Title: | Evaluating Group-based (ADAPT) Versus One-to-one (Usual) Occupational Therapy on Ability to Perform Activities of Daily Living (ADL) in People With Chronic Conditions (Go:OT Trial) |
Actual Study Start Date : | September 4, 2023 |
Estimated Primary Completion Date : | September 27, 2024 |
Estimated Study Completion Date : | December 6, 2024 |
Arm | Intervention/treatment |
---|---|
Experimental: ADAPT Program
The ADAPT Program is a structured and individualized group-based program
|
Behavioral: The ADAPT Program
The ADAPT Program is a structured and individualized 10-week group-based program, in which two occupational therapists teach groups of people, the skills of problem-solving more efficiently as means to overcome ADL task performance problems. The ADAPT Program 3.0 includes 2 individual two-hour sessions (sessions 1 and 10) conducted in the clients homes and eight two-hour group-based sessions (sessions 2-9). Moreover, two booster sessions (sessions 11 and 12) are delivered to support sustainable gains after termination of the 10-week ADAPT Program 3.0
Other Names:
|
Active Comparator: Usual Occupational Therapy (UOT)
UOT is delivered by one occupational therapist in the clients homes or local environments. .
|
Behavioral: UOT
UOT is delivered by one occupational therapist. Sessions are individualised and focused on improving ADL ability e.g. by practicing the performance of ADL task or adjusting home environments. UOT typically includes 7 one-to-one sessions of 60 minutes, delivered over a 10-week period in the clients´ homes. The dose is however not fixed but based on the occupational therapists´ clinical judgement in collaboration with the individual client
Other Name: Usual occupational therapy |
- Change in observed ADL motor ability, Assessment of Motor and Process Skills (AMPS) [ Time Frame: week 12 ]Observation-based ADL motor ability (reflecting physical effort and independence ). Linear measures of ADL motor ability generated using Rasch measurement models. Higher scores mean better ADL ability
- Change in observed ADL motor ability, using AMPS [ Time Frame: week 26 ]Observation-based ADL motor ability (reflecting physical effort and independence ). Linear measures of ADL motor ability generated using Rasch measurement models. Higher scores mean better ADL ability
- Change in observed ADL process ability, using AMPS [ Time Frame: week 12 ]Observation-based ADL process ability (reflecting efficiency, safety and independence). Linear measures of ADL process ability generated using Rasch measurement models. Higher scores mean better ADL ability
- Change in observed ADL process ability, using AMPS [ Time Frame: week 26 ]Observation-based ADL process ability (reflecting efficiency, safety and independence). Linear measures of ADL process ability generated using Rasch measurement models. Higher scores mean better ADL ability
- Change in self-reported ADL ability, using the ADL-Interview (ADL-I), Performance scale [ Time Frame: week 12 ]Self-reported ability to perform ADL tasks, based on interview. Linear measures of ADL ability generated using Rasch measurement models. Higher scores mean better ADL ability
- Change in self-reported ADL ability with ADL-I, Performance scale [ Time Frame: week 26 ]Self-reported ability ot perform ADL tasks, based on interview. Linear measures of ADL ability generated using Rasch measurement models. Higher scores mean better ADL ability
- Change in self-reported satisfaction with ADL ability, using ADL-I, Satisfaction scale [ Time Frame: week 12 ]Self-reported satisfaction with ADL task performance, based on interview. Linear measures of ADL ability generated using Rasch measurement models. Higher scores means higher satisfaction
- Change in self-reported satisfaction with ADL ability, using the ADL-Interview (ADL-I), Satisfaction scale [ Time Frame: week 26 ]Self-reported satisfaction with ADL task performance, based on interview. Linear measures of ADL ability will be generated using Rasch measurement models. Higher scores means higher satisfaction
- Well-being, using the World Health Organisation- Five Well-Being Index (WHO-5) [ Time Frame: week 12 ]Participants are asked to rate well being in regard to five questions. Response options are scored on a 6-point scale in which 0=at no time to 0=all the time. Lower scores are lower well-being
- Well-being, using The World Health Organisation- Five Well-Being Index (WHO-5) [ Time Frame: week 26 ]Participants are asked to rate well being in regard to five questions. Response options are scored on a 6-point scale in which 0=at no time to 0=all the time. Lower scores are lower well-being
- Quality of life, using the EuroQoL 5 dimensions (EQ-5D) [ Time Frame: week 12 ]Participants are asked to rate 5 aspects of health-related quality of life Quality of life in regard to five items scores on a 5 point likert scale from I am not/have none to I have extreme/i cannot
- Quality of life, using EQ-5D [ Time Frame: week 26 ]Participants are asked to rate 5 aspects of health-related quality of life Quality of life in regard to five items scores on a 5 point likert scale from I am not/have none to I have extreme/i cannot
- Perceived change in ADL task performance, TRANS-Questionnaire [ Time Frame: week 12 ]Participants are asked about their experienced change in a) performance of ADL tasks and b) satisfaction witt their ADL ability following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly worse' to 'markedly better'
- Perceived change in ADL task performance, TRANS-Questionnaire [ Time Frame: week 26 ]Participants are asked about their experienced change in a) performance of ADL tasks and b) satisfaction witt their ADL ability following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly worse' to 'markedly better'
- Perceived change in problem-solving skills, TRANS-Questionnaire [ Time Frame: week 12 ]Participants are asked about their experienced change in a) identifying daily task performance problems and b) the ability to solve task performance problems following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly worsened' to 'markedly better'
- Perceived change in problem-solving skills, TRANS-Questionnaire [ Time Frame: week 26 ]Participants are asked about their experienced change in a) identifying daily task performance problems and b) the ability to solve task performance problems following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly worsened' to 'markedly better'
- Perceived change in Quality of Life, TRANS-Questionnaire [ Time Frame: week 12 ]Participants are asked about their experienced change in a) overall functioning, b) mental well-being, c) physical well-being and d) social well-being following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly bigger' to 'markedly less'
- Perceived change in Quality of Life, TRANS-Questionnaire [ Time Frame: week 26 ]Participants are asked about their experienced change in a) overall functioning, b) mental well-being, c) physical well-being and d) social well-being following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly bigger' to 'markedly less'
- Perceived change in global health, TRANS-Questionnaire [ Time Frame: week 12 ]Participants are asked about their experienced change in global health following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly worse' to 'markedly better'
- Perceived change in global health, TRANS-Questionnaire [ Time Frame: week 26 ]Participants are asked about their experienced change in global health following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly worse' to 'markedly better'
- Perceived change in assistance needed, TRANS-Questionnaire [ Time Frame: week 12 ]Participants are asked about their experienced change in needing assistance in a) findings ways to ease task performance, b) accepting my chronic condition, c) managing symptoms following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly bigger' to 'markedly less'
- Perceived change in assistance needed, TRANS-Questionnaire [ Time Frame: week 26 ]Participants are asked about their experienced change in needing assistance in a) findings ways to ease task performance, b) accepting my chronic condition, c) managing symptoms following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly bigger' to 'markedly less' less
- Overall experience of the occupational therapy intervention [ Time Frame: week 12 ]Participants are asked to rate their experience on a 5 point Likert scale ranging from "excellent' to 'very poor'
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion criteria:
- ≥ one year since medical diagnosed with one or more chronic conditions.
- Lives in own home.
- Experience ADL task performance problems.
- Show ADL motor ability measures <1.50 logits on the AMPS ADL motor skill scale (indicate increased effort during ADL task performance).
- Communicate independently and relevantly orally and in writing.
- Willing and interested in attending occupational therapy interventions focused on improving ADL task performance.
Exclusion criteria:
- ADL process ability measures <0.00 indicating that the person is unlikely to profit from educational programs focused on using adaptational strategies.
- Personal ADL (PADL) problems with acute need for help.
- Mental illness and/or other acute (<3 months) conditions effecting ADL task performance significantly.
- Significant communication barriers (significant cognitive deficits, -aphasia, -hearing loss, -dyslexia and/or -language barriers).
- Known substance abuse.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06058754
Contact: Cecilie von Bülow, PhD | 38164147 | Cecilie.von.bulow@regionh.dk | |
Contact: Eva Wæhrens, Professor | 38164166 | eva.elisabet.waehrens@regionh.dk |
Denmark | |
The Parker Research Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg Frederiksberg, Denmark | Recruiting |
Frederiksberg, Denmark, 2000 | |
Contact: Cecilie von Bülow 38164147 Cecilie.von.bulow@regionh.dk | |
Contact: Eva Wæhrens 38 16 41 66 eva.elisabet.waehrens@regionh.dk |
Principal Investigator: | Cecilie von Bülow, PhD | Parker Institute, Bispebjerg and Frederiksberg Hospital |
Responsible Party: | Eva Ejlersen Wæhrens, Senior researcher, Associate Professor, Parker Research Institute |
ClinicalTrials.gov Identifier: | NCT06058754 |
Other Study ID Numbers: |
Parker Institute, |
First Posted: | September 28, 2023 Key Record Dates |
Last Update Posted: | September 28, 2023 |
Last Verified: | September 2023 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Occupational therapy ADL Adaptation |
Chronic condition Peer-exchange group-based |
Disease Chronic Disease Multiple Chronic Conditions Pathologic Processes Disease Attributes |